Oh I did too. And all my shares at that point were $.29. Epic fail. But I still did well on my CYDY for sure. Unfortunately that has now all been given back, plus a big chunk, via HGEN.Well, I held CYDY stock when it hit $10.01. Kicking myself now.
@Whyatt, any thoughts on today's news and action? I have a small position at just under $17, wondering if any point in holding or just time to move on.Definitely a bunch based on the stock thread. I think only that Whyatt guy was really heavily invested (some others probably had a good chunk), but he was the guy who got people into it. Based on the split, it was in the 30s back when the investment angle popped up. I didn’t feel like getting into the same ride again. I feel really lucky to have made a nice chunk of change on one based on both companies’ current price.
Yes, SF, I have plenty of thoughts.SFBayDuck said:@Whyatt, any thoughts on today's news and action? I have a small position at just under $17, wondering if any point in holding or just time to move on.
The other fallout from yesterday is it makes it unlikely England approves. Oh well, back to waiting.Yes, SF, I have plenty of thoughts.
Developing therapeutics for Covid has proven to be really difficult, virtually every program has been delayed, failed, or otherwise challenged. I’m really struggling with how a Lenz’s successful P3 trial which had input from US government (BARDA, OWS) is somehow not viewed as sufficient for EUA. This is after FDA review and being encouraged to submit an EUA application. Seems HGEN was set to fail here.
I think the ongoing NIH trial will be successful, but it won’t be completed until year end. Meanwhile material events could happen, like approval in other countries, but I’m not counting on it. So we could be looking at 6 months of scraping the bottom here. That said, I think Lenz will eventually be approved drug in 2022 and could have a intrinsic value of 3 to 5 billion, vs HGENs current market cap of < 500 million. The company isn’t in danger of running out of cash.
So I’m a bag holder here.
As I’m in at an around a 19 holding seems like my only real opinion. I’ve already lost 2/3 of my investment. Might as well hope for some kind of rebound.The other fallout from yesterday is it makes it unlikely England approves. Oh well, back4 hours ago, Whyatt said:
Yes, SF, I have plenty of thoughts.
Developing therapeutics for Covid has proven to be really difficult, virtually every program has been delayed, failed, or otherwise challenged. I’m really struggling with how a Lenz’s successful P3 trial which had input from US government (BARDA, OWS) is somehow not viewed as sufficient for EUA. This is after FDA review and being encouraged to submit an EUA application. Seems HGEN was set to fail here.
I think the ongoing NIH trial will be successful, but it won’t be completed until year end. Meanwhile material events could happen, like approval in other countries, but I’m not counting on it. So we could be looking at 6 months of scraping the bottom here. That said, I think Lenz will eventually be approved drug in 2022 and could have a intrinsic value of 3 to 5 billion, vs HGENs current market cap of < 500 million. The company isn’t in danger of running out of cash.
So I’m a bag holder here.
Expand
Lol I just bought more. Me ->As I’m in at an around a 19 holding seems like my only real opinion. I’ve already lost 2/3 of my investment. Might as well hope for some kind of rebound.
Maybe the takeover is happening? Who's counting the votes, and when is the deadline?up 14% on....what?
Understatement, no idea why its up so much today.unckeyherb said:What a weird stock.
Still don’t understand how with no US approval any other country approves it. And there’s no US trial (that I know of).I guess there was a call today? I used to be pretty on top of when calls were going to happen, barely care right now.
Was checking the various boards though and the longs seem to think it went well. They are excited about the Philippines again? Can't trust any of these people but they seem to think something good is about to happen.
Still don’t understand how with no US approval any other country approves it. And there’s no US trial (that I know of).
It was a "conference". A "conference" that CYDY paid to be in attendance. I believe these "conferences" are run like 3 times a week.I guess there was a call today? I used to be pretty on top of when calls were going to happen, barely care right now.
Was checking the various boards though and the longs seem to think it went well. They are excited about the Philippines again? Can't trust any of these people but they seem to think something good is about to happen.
I would just wait until it inevitably gets back into the 1.30 range or even 1.20s.Got back in the game with a small buy. At this price what the hell. Sure it will not work out for me.
It’s not enough to care. Just bought some to watch. Probably will unload if it goes up another 10%.I would just wait until it inevitably gets back into the 1.30 range or even 1.20s.
If nothing else this is a great stock to trade.
pffftt. Typical American!Still don’t understand how with no US approval any other country approves it. And there’s no US trial (that I know of).
I can't see this continuing, this run is surprising even by CYDY standards.Up 21% since I bought the other day. Will probably unload today if a 3:00 pump happens.
Yea that’s my thinking. Unload today or tomorrow, get back in on the dip. There is no catalyst for this to surge to 3 or 4 anytime soon, at least not before I could get back in.I can't see this continuing, this run is surprising even by CYDY standards.
I will reload though on the next dip into the 1.30s, you can't keep this thing down for good
When it hits 200. ThanksLet me know when you guys need this to drop again. I'll buy again and it will immediately tank.
This guy: https://en.wikipedia.org/wiki/Greco_Belgicaalso in the FB group, an article about another well know person in the Phillipines seeing a dramatic turn around after taking LL.
So I still don’t get the long term plan? Approval in Brazil?unckeyherb said:
Seems like a nice run up if you bought at the bottom, but long term, it does seem like they’ve given up on the US. I guess than long hauler thing is still going, which is important. One of my wife’s co-workers got it (she regrets not vaccinating, damn misinformation), but she has said she’s still foggy at times. I bet there’s going to be a lot of that so medicine that could help with that is still important, but might not be a huge money maker. Also, that other group seems to have been knocked around so it’s funny that people were hoping for the white knight but that seems to have faded and the stock’s up.So I still don’t get the long term plan? Approval in Brazil?
Have they totally given up on the US?
We love that story grandpa.You know, I haven’t said I’m glad I sold for a while, but I guess I don’t feel like bringing it up anymore.